GT Biopharma, Inc. — Form D
GT Biopharma, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-28. The offering totals $20.0M. Industry: Biotechnology.
Offering
- Filed: 2025-05-28
- Form: D
- Accession: 0001641172-25-012695
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Remaining: $20.0M
- Investors: 2
- Date of first sale: 2025-05-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-547407
Issuer
- Name: GT Biopharma, Inc.
- CIK: 0000109657
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 505 MONTGOMERY STREET, SAN FRANCISCO, CA, 94111
- Phone: 800-304-9888
Officers, directors & promoters (25)
| Name | Role | Location |
|---|
| Michael Breen | Director | SAN FRANCISCO, CA |
| Charles Casamento | Director | SAN FRANCISCO, CA |
| Hilary Kramer | Director | SAN FRANCISCO, CA |
| Andrew Ritter | Director | SAN FRANCISCO, CA |
| Michael Breen | Executive Officer | SAN FRANCISCO, CA |
| Alan Urban | Executive Officer | SAN FRANCISCO, CA |
| Anshuman Dube | Director | Las Vegas, NV |
| Bruce Wendel | Director | San Francisco, CA |
| Rajesh Shrotriya | Director | San Francisco, CA |
| Steven Weldon | Director | Beverly Hills, CA |
| Steven Weldon | Executive Officer | Beverly Hills, CA |
| Anthony Cataldo | Director | Beverly Hills, CA |
| Anthony Cataldo | Executive Officer | Beverly Hills, CA |
| Kathleen J Clarence-Smith | Director | TAMPA, FL |
| Kathleen J Clarence-Smith | Executive Officer | TAMPA, FL |
| Anthony J Cataldo | Director | TAMPA, FL |
| Jon B Bonfiglio | Director | TAMPA, FL |
| Raymond B Urbanski | Executive Officer | TAMPA, FL |
| Peter B Kiener | Director | TAMPA, FL |
| Geoffrey B Davis | Director | TAMPA, FL |
| Kathleen Clarence-Smith | Director | Washington, DC |
| Kathleen Clarence-Smith | Executive Officer | Washington, DC |
| David Saloff | Director | Beverly Hills, CA |
| Kenneth Eaton | Director | Beverly Hills, CA |
| Kenneth Eaton | Executive Officer | Beverly Hills, CA |
Other filings by this issuer (10)
More